Standard BioTools Inc (LAB)
2.48
-0.08
(-3.12%)
USD |
NASDAQ |
May 31, 16:00
2.475
0.00 (0.00%)
After-Hours: 20:00
Standard BioTools Cash and Short Term Investments (Quarterly): 462.28M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 462.28M |
December 31, 2023 | 114.90M |
September 30, 2023 | 128.85M |
June 30, 2023 | 142.30M |
March 31, 2023 | 154.54M |
December 31, 2022 | 165.78M |
September 30, 2022 | 185.17M |
June 30, 2022 | 211.21M |
March 31, 2022 | 29.98M |
December 31, 2021 | 28.45M |
September 30, 2021 | 29.31M |
June 30, 2021 | 30.86M |
March 31, 2021 | 49.74M |
December 31, 2020 | 68.52M |
September 30, 2020 | 72.34M |
June 30, 2020 | 45.40M |
March 31, 2020 | 48.48M |
December 31, 2019 | 58.64M |
September 30, 2019 | 62.76M |
June 30, 2019 | 68.86M |
March 31, 2019 | 75.13M |
December 31, 2018 | 95.40M |
September 30, 2018 | 35.83M |
June 30, 2018 | 40.42M |
March 31, 2018 | 47.25M |
Date | Value |
---|---|
December 31, 2017 | 63.14M |
September 30, 2017 | 62.37M |
June 30, 2017 | 42.03M |
March 31, 2017 | 50.28M |
December 31, 2016 | 59.43M |
September 30, 2016 | 71.25M |
June 30, 2016 | 86.41M |
March 31, 2016 | 95.22M |
December 31, 2015 | 94.97M |
September 30, 2015 | 97.07M |
June 30, 2015 | 99.93M |
March 31, 2015 | 116.41M |
December 31, 2014 | 115.30M |
September 30, 2014 | 95.26M |
June 30, 2014 | 94.74M |
March 31, 2014 | 143.15M |
December 31, 2013 | 84.34M |
September 30, 2013 | 63.68M |
June 30, 2013 | 60.43M |
March 31, 2013 | 79.57M |
December 31, 2012 | 80.01M |
September 30, 2012 | 86.16M |
June 30, 2012 | 37.87M |
March 31, 2012 | 38.88M |
December 31, 2011 | 53.47M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
28.45M
Minimum
Dec 2021
462.28M
Maximum
Mar 2024
107.92M
Average
68.69M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Bruker Corp | 340.10M |
Azenta Inc | 821.71M |
Harvard Bioscience Inc | 4.255M |
Bionano Genomics Inc | 52.77M |
Akoya Biosciences Inc | 61.58M |